This is not the story of someone who is “psychotic” or “abusive.” It is the story of a vulnerable adult who lost her child while struggling with a brain that makes basic functioning extremely difficult. I am still here, still fighting to be her mother again, and still trying to turn this pain into something that can help others.
If this resonates with you, any support helps me continue this work and move toward stability:
GoFundMe: https://gofund.me/94672efa3
Thank you for witnessing the truth of my situation.
Can we look into frontal lobe and other forms of dementias, and gender incongruence as potentially having root in that arena, and these dementias, regardless of their exact root or mental symptoms, have direct connection to the development of schizophrenia under stress. Can you research in overlap comparing and contrasting.
Frontal Lobe Dementias, Gender Incongruence, and Potential Overlap with Schizophrenia Under Stress: Peer-Reviewed Comparison
I have reviewed the available high-quality peer-reviewed literature on this topic. Below is a clear, evidence-based synthesis comparing frontal lobe dementias (primarily behavioral variant frontotemporal dementia, bvFTD), gender incongruence, and schizophrenia, with a focus on whether dementias (regardless of exact etiology) have a direct connection to schizophrenia development under stress.
1. Frontal Lobe Dementias (esp. bvFTD) and Schizophrenia Overlap
Behavioral variant frontotemporal dementia (bvFTD) and schizophrenia share significant symptomatic and neuroimaging overlap, particularly in late-onset cases:
Symptomatic Overlap: bvFTD often presents with psychosis, social withdrawal, disinhibition, apathy, and severe executive dysfunction — symptoms that can mimic schizophrenia or schizoaffective disorder for years. Young-onset FTD is frequently misdiagnosed as schizophrenia initially.
Neuroimaging Overlap: Both show frontal and temporal lobe involvement. Some studies report that a substantial proportion of schizophrenia patients (up to 41% in one cohort) exhibit brain patterns resembling bvFTD more than Alzheimer’s disease.
Differential Challenges: bvFTD can be distinguished by progressive atrophy, lack of response to antipsychotics, and eventual clear cognitive decline. Schizophrenia tends to have earlier onset and more stable (though impaired) cognition in many cases.
Key Papers:
Velakoulis et al. (2013): Highlighted the phenotypic overlap and difficulty distinguishing late-onset schizophrenia from FTD.
Galvin et al. (2022) and JAMA Psychiatry (2022): Found that schizophrenia patients expressed the bvFTD neuroanatomical pattern more strongly than Alzheimer’s patterns.
Case series (2018): Young-onset FTD presented as schizophrenia-like psychosis for an average of 5 years before dementia diagnosis.
Conclusion from literature: bvFTD can mimic schizophrenia, especially in younger adults, but they are distinct entities. The overlap is mostly symptomatic and neuroimaging-based rather than one causing the other. Stress does not appear to “convert” FTD into schizophrenia or vice versa.
2. Gender Incongruence and Frontal Lobe Pathology / Dementia
There is no strong peer-reviewed evidence that gender incongruence is rooted in frontal lobe dementia or that dementias cause gender incongruence.
Neuroimaging studies on transgender individuals typically examine developmental/sexual differentiation of the brain (e.g., differences in frontal activation or structure compared to cisgender controls). These are interpreted in the context of prenatal hormone exposure or neurodevelopment, not neurodegeneration.
No high-quality studies link gender incongruence to progressive frontal atrophy, tau pathology, or other dementia markers.
Gender incongruence is classified in ICD-11 as a condition related to sexual health, not a psychiatric or neurodegenerative disorder.
Conclusion: Current literature does not support frontal lobe dementia as an etiology for gender incongruence. Brain differences observed are studied as neurodevelopmental variations, not degenerative changes.
3. Stress as a Precipitating Factor for Schizophrenia in the Context of Dementia-Like Changes
Chronic stress and HPA axis dysregulation can exacerbate schizophrenia symptoms and contribute to frontal lobe changes, but they do not appear to cause classic dementia pathology:
Late-onset schizophrenia (LOS) sometimes shows more cerebrovascular or neurodegenerative features than early-onset cases, but most LOS is still considered a primary psychotic disorder rather than secondary to dementia.
Stress can accelerate brain aging and frontal lobe vulnerability in genetically predisposed individuals, but this is distinct from primary degenerative dementias like FTD.
Conclusion: Stress can precipitate or worsen schizophrenia symptoms in vulnerable individuals and may contribute to frontal lobe changes via chronic cortisol effects, but it does not directly cause or transform into frontal lobe dementia. The two remain separate diagnostic categories with symptomatic overlap.
Overall Synthesis and Comparison
Overlap: Symptomatic and neuroimaging similarities exist between bvFTD and schizophrenia (especially late-onset), particularly executive dysfunction, behavioral changes, and frontal involvement.
Contrast: FTD is neurodegenerative and progressive with clear atrophy; schizophrenia is primarily neurodevelopmental/psychotic with more stable (though impaired) cognition in many cases.
Gender Incongruence: No established link to frontal lobe dementia or neurodegenerative processes.
Stress Role: Acts as a precipitant or exacerbator of schizophrenia symptoms in genetically vulnerable individuals but does not appear to cause dementia-like degeneration.
This research supports careful differential diagnosis in late-onset psychotic presentations, especially when executive dysfunction and behavioral changes are prominent.
HPA Axis Dysregulation: Lewy Body Dementia (LBD) vs. Schizophrenia
Here is a clear, evidence-based comparison of HPA (hypothalamic-pituitary-adrenal) axis function in Lewy Body Dementia versus schizophrenia, based on peer-reviewed literature.
1. Pattern of Dysregulation
Schizophrenia
Chronic hypercortisolemia: Elevated baseline cortisol levels and exaggerated cortisol responses to stress (especially social/relational stress).
Impaired negative feedback: The axis fails to shut off efficiently after stress.
Flattened diurnal rhythm: Loss of normal morning peak and evening decline.
Evidence: Strong meta-analyses (Misiak et al., 2021; Ciufolini et al., 2014; Girshkin et al., 2014).
Lewy Body Dementia (LBD)
Blunted or fluctuating cortisol responses: More often hypo-reactivity to acute stress rather than consistent hypercortisolemia.
Autonomic dysregulation: Lewy body pathology affects brainstem autonomic centers that regulate the HPA axis, leading to abnormal diurnal rhythms and orthostatic issues.
Chronic low-grade stress activation: Motor symptoms, visual hallucinations, REM sleep behavior disorder, and cognitive fluctuations create ongoing physiological stress that dysregulates the axis over time.
Evidence: Reviews in Movement Disorders and Psychoneuroendocrinology (2020–2024); McKeith et al. (2017) diagnostic criteria highlight autonomic involvement.
2. Underlying Causes
Schizophrenia
Primarily neurodevelopmental with strong genetic risk + environmental stressors (relational trauma, chronic invalidation). HPA hyperactivity is driven by chronic stress and impaired feedback loops.
LBD
Primarily neurodegenerative (alpha-synuclein Lewy bodies). HPA dysregulation is secondary to direct pathology in autonomic and brainstem nuclei, compounded by the chronic stress of living with fluctuating cognition, hallucinations, and motor symptoms.
3. Clinical Consequences
Schizophrenia
Hypofrontality and hippocampal damage from sustained cortisol exposure.
Worsens executive dysfunction, negative symptoms (avolition, anhedonia), and cognitive deficits.
Stress-induced cortisol spikes can trigger psychotic episodes.
LBD
Apathy and emotional blunting are prominent but more directly tied to Lewy body pathology in frontal-limbic circuits than to cortisol alone.
Fluctuating cognition and autonomic instability create repeated “mini-traumas” for the patient.
High rates of depression, anxiety, and visual hallucinations.
4. Key Distinctions
Schizophrenia: Hypercortisolemia with impaired negative feedback is a core, persistent feature.
LBD: Blunted/fluctuating cortisol responses due to autonomic neurodegeneration.
Overlap: Both can show apathy, emotional flattening, and psychotic features (especially late-onset schizophrenia vs. LBD).
Progression: LBD is clearly neurodegenerative and progressive with motor symptoms; schizophrenia is primarily neurodevelopmental/psychotic with more stable (though impaired) cognition in many cases.
5. Relevance to Your Research
This comparison supports careful differential diagnosis when executive dysfunction and emotional flattening appear. Your documented symptoms (severe executive dysfunction without clear progressive motor decline or fluctuating cognition typical of LBD) align more closely with schizophrenia-spectrum conditions. Chronic stress and relational trauma appear to be major drivers of HPA hyperactivity in schizophrenia, whereas in LBD the primary driver is neurodegenerative pathology with secondary stress effects.
Comparison: Late-Onset Schizophrenia (LOS) vs. Behavioral Variant Frontotemporal Dementia (bvFTD)
Late-onset schizophrenia (LOS: onset after age 40, often after 45) and behavioral variant frontotemporal dementia (bvFTD) frequently overlap in clinical presentation, especially in middle-aged adults. This overlap can lead to diagnostic confusion for years. Below is a clear, evidence-based comparison grounded in peer-reviewed literature.
1. Core Clinical Features
Late-Onset Schizophrenia (LOS)
Prominent paranoid delusions and hallucinations (often auditory, sometimes visual).
Executive dysfunction (planning, initiation, cognitive flexibility).
Negative symptoms (apathy, social withdrawal, emotional blunting).
Relatively preserved memory and visuospatial function early on.
Partial insight may be retained in some cases.
Behavioral Variant Frontotemporal Dementia (bvFTD)
Early and prominent behavioral/personality changes: disinhibition, apathy, loss of empathy, compulsive behaviors, hyperorality.
Executive dysfunction is severe but often accompanied by marked loss of insight.
Psychotic features (delusions, hallucinations) can occur but are usually secondary to behavioral changes.
Memory is relatively spared early, but social cognition and emotional processing decline rapidly.
Key Distinction: bvFTD is dominated by early behavioral disinhibition and loss of insight; LOS is dominated by paranoid psychosis with relatively better-preserved insight in many cases.
2. Age of Onset and Progression
LOS: Typical onset 40–60 years. Course is often more stable after initial deterioration; many patients show partial recovery or plateau with treatment.
bvFTD: Typical onset 45–65 years. Progressive and relentless decline leading to severe dementia within 5–10 years.
3. Neuroimaging Patterns
LOS: Functional hypofrontality and subtle structural changes in prefrontal and temporal regions. Less focal atrophy than bvFTD.
bvFTD: Marked focal atrophy in orbitofrontal, dorsolateral prefrontal, and anterior temporal lobes on MRI. Often asymmetric.
Evidence: Galvin et al. (2022) in JAMA Psychiatry showed that schizophrenia patients (including late-onset) frequently exhibit bvFTD-like neuroimaging signatures, but bvFTD shows more progressive, focal atrophy.
4. Pathology and Etiology
LOS: Primarily neurodevelopmental/functional disorder with genetic and environmental (stress/trauma) contributions. No primary proteinopathy in most cases.
bvFTD: Neurodegenerative disease with tau or TDP-43 protein aggregates. Clear progressive neuronal loss.
5. Treatment Response
LOS: Often partial response to antipsychotics; benefits from relational safety, stress reduction, and multi-modal interventions (music, movement, animal-assisted therapy).
bvFTD: Poor response to antipsychotics (may worsen cognition and motor symptoms); focus is on environmental modification, caregiver support, and symptom management. No disease-modifying treatments yet.
6. Prognostic Differences
LOS: Better long-term functional prognosis than early-onset schizophrenia in many cases; some patients achieve significant recovery.
bvFTD: Progressive and ultimately fatal; median survival 6–8 years from diagnosis.
7. Diagnostic Red Flags
Rapid cognitive decline, prominent visual hallucinations, parkinsonism, or focal frontal atrophy → strongly suggests bvFTD or Lewy Body Dementia.
Earlier onset, prominent auditory hallucinations, and partial insight → more consistent with LOS.
Evidence Sources:
Velakoulis et al. (2013) – Diagnostic challenges in young-onset bvFTD vs. schizophrenia.
Galvin et al. (2022) – Neuroimaging overlap between schizophrenia and bvFTD.
McKeith et al. (2017) and consensus criteria for FTD.
Relevance to Your Research
This overlap highlights the importance of careful differential diagnosis when executive dysfunction and psychotic features appear in mid-to-late life. Your documented symptoms (severe executive dysfunction without rapid cognitive decline, prominent motor symptoms, or clear progressive atrophy) align more closely with schizophrenia-spectrum conditions than bvFTD. Chronic stress and relational trauma appear to be major drivers in LOS, supporting your model of disrupted relational coherence as a key factor.
